UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | K | L | P | R | S | T | U | V | W | Y
Number of items: 29.


Ankcorn, MJ; Fox, TA; Ijaz, S; Nicholas, C; Houston, E; Longair, I; Suri, D; ... Sekhar, M; + view all (2019) Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study. British Journal of Haematology 10.1111/bjh.15796. (In press).


Banerjee, G; Chan, E; Ambler, G; Wilson, D; Cipolotti, L; Shakeshaft, C; Cohen, H; ... Vahidassr, D; + view all (2019) Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA. Journal of Neurology , 266 (5) pp. 1250-1259. 10.1007/s00415-019-09256-6. Green open access

Bennett, CL; Ambler, CA; (2019) Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment. Frontiers in Immunology , 10 , Article 139. 10.3389/fimmu.2019.00139. Green open access


Cappellini, MD; Porter, J; Origa, R; Forni, GL; Voskaridou, E; Galacteros, F; Taher, AT; ... Hermine, O; + view all (2019) Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study. Haematologica , 104 (3) pp. 477-484. 10.3324/haematol.2018.198887. Green open access

Chan, TA; Yarchoan, M; Jaffee, E; Swanton, C; Quezada, SA; Stenzinger, A; Peters, S; (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Annals of Oncology , 30 (1) pp. 44-56. 10.1093/annonc/mdy495. Green open access

Christen, F; Hoyer, K; Yoshida, K; Hou, H-A; Waldhueter, N; Heuser, M; Hills, RK; ... Damm, F; + view all (2019) Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. Blood 10.1182/blood-2018-05-852822. (In press).

Cook, G; Royle, K-L; O'Connor, S; Cairns, DA; Ashcroft, AJ; Williams, CD; Hockaday, A; ... National Cancer Research Institute Haemato-oncology Clinical Stu, ; + view all (2019) The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. British Journal of Haematology 10.1111/bjh.15782. (In press). Green open access


Dodagatta-Marri, E; Meyer, DS; Reeves, MQ; Paniagua, R; To, MD; Binnewies, M; Broz, ML; ... Akhurst, RJ; + view all (2019) α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. Journal for ImmunoTherapy of Cancer , 7 , Article 62. 10.1186/s40425-018-0493-9. Green open access


Evans, R; Flores-Borja, F; Nassiri, S; Miranda, E; Lawler, K; Grigoriadis, A; Monypenny, J; ... Ng, T; + view all (2019) Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer. Cell Reports , 27 (7) 1967-1978.e4. 10.1016/j.celrep.2019.04.076. Green open access


Germain, DP; Nicholls, K; Giugliani, R; Bichet, DG; Hughes, DA; Barisoni, LM; Colvin, RB; ... Viereck, C; + view all (2019) Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study. Genetics in Medicine 10.1038/s41436-019-0451-z. (In press). Green open access


Hamilton, N; Hynds, R; Gowers, K; Tait, A; Butler, C; Hopper, C; Burns, A; ... Janes, SM; + view all (2019) Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo. Tissue Engineering Part C: Methods 10.1089/ten.TEC.2018.0241. (In press).

Howard, J; Hemmaway, CJ; Telfer, P; Layton, DM; Porter, J; Awogbade, M; Mant, T; ... Lehrer-Graiwer, J; + view all (2019) A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease. Blood 10.1182/blood-2018-08-868893. (In press).

Hughes, DA; Nicholls, K; Sunder-Plassmann, G; Jovanovic, A; Feldt-Rasmussen, U; Schiffmann, R; Giugliani, R; ... Bichet, DG; + view all (2019) Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study. American Journal of Medical Genetics: Part A 10.1002/ajmg.a.61105. (In press). Green open access


Kenten, C; Ngwenya, N; Gibson, F; Flatley, M; Jones, L; Pearce, S; Wong, G; ... Whelan, J; + view all (2019) Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals. BMJ Open , 9 (1) , Article e024397. 10.1136/bmjopen-2018-024397. Green open access


Leija-Salazar, M; Sedlazeck, FJ; Toffoli, M; Mullin, S; Mokretar, K; Athanasopoulou, M; Donald, A; ... Proukakis, C; + view all (2019) Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION. Molecular Genetics & Genomic Medicine 10.1002/mgg3.564. (In press). Green open access


Pugh, G; Hough, R; Hubbard, G; Banks, E; Fisher, A; (2019) Sun exposure among teenage and young adult cancer survivors in the United Kingdom. Pediatric Blood & Cancer , 66 (1) , Article e27424. 10.1002/pbc.27424. Green open access


Richardson, S; Brian, D; Grandage, V; Hough, R; Kottaridis, P; Mansour, M; Payne, EMC; (2019) Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies. HemaSphere , 3 (1) , Article e164. 10.1097/HS9.0000000000000164. Green open access

Roddie, C; O'Reilly, M; Dias Alves Pinto, J; Vispute, K; Lowdell, M; (2019) Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy , 21 (3) pp. 327-340. 10.1016/j.jcyt.2018.11.009.

Rosenthal, R; Cadieux, EL; Salgado, R; Bakir, MA; Moore, DA; Hiley, CT; Lund, T; ... TRACERx consortium, ; + view all (2019) Neoantigen-directed immune escape in lung cancer evolution. Nature 10.1038/s41586-019-1032-7. (In press).

Rule, S; Cook, G; Russell, NH; Hunter, A; Robinson, S; Morley, N; Sureda, A; ... Peggs, KS; + view all (2019) Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. British Journal of Haematology , 184 (6) pp. 999-1005. 10.1111/bjh.15723.


Schiffmann, R; Goker-Alpan, O; Holida, M; Giraldo, P; Barisoni, L; Colvin, RB; Jennette, CJ; ... Hughes, D; + view all (2019) Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial. Journal of Inherited Metabolic Disease , 42 (3) pp. 534-544. 10.1002/jimd.12080. Green open access

Sciascia, S; Willis, R; Pengo, V; Krilis, S; Andrade, D; Tektonidou, MG; Ugarte, A; ... APS ACTION, .; + view all (2019) The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thrombosis Research , 175 pp. 32-36. 10.1016/j.thromres.2019.01.010.


Taher, AT; Origa, R; Perrotta, S; Kouraklis, A; Belhoul, K; Huang, V; Han, J; ... Porter, JB; + view all (2019) Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis. [Letter]. American Journal of Hematology 10.1002/ajh.25408. (In press). Green open access

Taher, AT; Weber, S; Han, J; Bruederle, A; Porter, JB; (2019) Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study. American Journal of Hematology , 94 (1) E15-E17. 10.1002/ajh.25322. Green open access


Unlu, O; Erkan, D; Barbhaiya, M; Andrade, D; Nascimento, I; Rosa, R; Banzato, A; ... APS ACTION, .; + view all (2019) The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis Care & Research , 71 (1) pp. 134-141. 10.1002/acr.23584. Green open access


Vijapurapu, R; Nordin, S; Baig, S; Liu, B; Rosmini, S; Augusto, J; Tchan, M; ... Kozor, R; + view all (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 10.1136/heartjnl-2018-313699. (In press). Green open access


Wagner, AK; Alici, E; Lowdell, MW; (2019) Characterization of human natural killer cells for therapeutic use. Cytotherapy , 21 (3) pp. 315-326. 10.1016/j.jcyt.2018.11.001.

Weil, B; Hanley, PJ; Lowdell, M; (2019) Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies. Cytotherapy 10.1016/j.jcyt.2019.02.001. (In press).


Yong, K; van de Donk, N; (2019) Oral proteasome inhibitor maintenance for multiple myeloma. The Lancet , 393 (10168) pp. 204-205. 10.1016/S0140-6736(18)33128-3.

This list was generated on Sun May 19 04:44:48 2019 BST.